Objective Interstitial lung disease (ILD) is the most severe complication of idiopathic
inflammatory myositis (IIM), resulting in significant increase in morbidity and mortality and for …

Interstitial lung disease (ILD) is a frequent pulmonary manifestation and an important cause
of morbidity and mortality in patients with idiopathic inflammatory myopathy. Myositis-related …

Inflammatory myopathies (IM) are auto-immune connective tissue diseases characterized by
muscle involvement and by extramuscular manifestations. As such, pulmonary …

Idiopathic inflammatory myopathies, including polymyositis (PM), dermatomyositis (DM), and
clinically amyopathic DM (CADM), are a diverse group of autoimmune diseases …

Objective. Patients with myositis-associated interstitial lung disease (MA-ILD) are often
refractory to conventional treatment, and predicting their response to therapy is challenging …

The idiopathic inflammatory myopathies (IIMs) affect more than 60,000 individuals in the
United States and an estimated 770,000 worldwide. 1 Although widely considered a disease …

Objective To identify initial predictors of poor survival in patients with PM/DM-associated
interstitial lung disease (ILD). Methods We established a multicentre retrospective cohort of …

Background Interstitial lung disease (ILD) is a common manifestation of polymyositis (PM),
dermatomyositis (DM), and clinically amyopathic dermatomyositis (CADM); however, little is …

The lung is one of the most common extra-muscular targets in idiopathic inflammatory
myopathies (IIM) and interstitial lung disease (ILD) is a prevalent and often devastating …

Aim To investigate the risk factors for interstitial lung disease (ILD) and prognosis in patients
with idiopathic inflammatory myopathy (IIM). Methods A retrospective longitudinal study was …